Compound Detail
CHEMBL1346
DARIFENACIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1346 |
| Name | DARIFENACIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | HXGBXQDTNZMWGS-RUZDIDTESA-N |
| Therapeutic | ✓ Yes |
17
Targets
35
Activities
4
Assay Types
12
PK Parameters
20
Publications
6
Known Names
4
Indications
Molecular Properties
426.6
MW (Da)
3.96
ALogP
3
HBA
1
HBD
55.6
PSA (Ų)
0.62
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2004 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Polyuria Urinary Incontinence Urinary Bladder, Overactive Amyotrophic Lateral Sclerosis
ATC Classification
G04BD10
darifenacin
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
Activity Summary
Ki 15 meas. best 9.13
EC50 10 meas. best 9.1
IC50 8 meas. best 7.1
Kd 2 meas. best 7.8
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 12.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.05 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 9.5 | mL.min-1.g-1 | Homo sapiens |
| CL | 50.96 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 594.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 12.0 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.02 | - | Homo sapiens |
| Fu | 0.02 | - | Homo sapiens |
| MRT | 3.6 | hr | Homo sapiens |
| T1/2 | 3.6 | hr | Homo sapiens |
| T1/2 | 7.6 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine